Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Real-world experience with front-line metronomic low-dose weekly decitabine and venetoclax in elderly and/or frail patients with MDS or AML

Adit Singhal, Pratik Shah, David Mueller, Lowena Tam, Stephanie Boisclair, Erin Jou, Bradley Goldberg, Jonathan Kolitz, Douglas Gladstone, David W. Chitty

Blood (2025) 146 (Supplement 1): 5186.

https://doi.org/10.1182/blood-2025-5186

Published: 2025

Journal Articles

17p cytogenetic changes in TP53-mutated AML

David Mueller, Sharon Santhosh, Adit Singhal, David W. Chitty, Douglas Gladstone, Bradley Goldberg, Erin Jou, Jonathan Kolitz, Stephanie Boisclair

Blood (2025) 146 (Supplement 1): 3506.

https://doi.org/10.1182/blood-2025-3506

Published: 2025

Journal Articles

Foreign antigen delivered to CLL B cells via membrane IgD leads to a distinct antigen processing pathway that allows antigen-specific T cell activation that is superior to membrane IgM delivery

Martina Cardillo, Matthew Friedman, Xiao Yan, Anita Kar Yun Ng, Randall Davis, Michael Ryan, Peter Gregersen, Steven Allen, Jonathan Kolitz, Kanti Rai, Paolo Ghia, Nicholas Chiorazzi

Blood (2025) 146 (Supplement 1): 3882.

https://doi.org/10.1182/blood-2025-3882

Published: 2025

Journal Articles

Predictors of 90-day mortality in elderly and unfit AML patients treated with single-agent hypomethylating agents or in combination with venetoclax

Melissa F. Neumann, Meredith Akerman, David Mueller, Nicholas Scelzi, Jasmine Cho, Aaron Goldstein, Shreya Sanghani, Stephanie Boisclair, Erin Jou, Bradley Goldberg, Jonathan Kolitz, Douglas Gladstone, Kanti Rai, David W. Chitty

Blood (2025) 146 (Supplement 1): 5166.

https://doi.org/10.1182/blood-2025-5166

Published: 2025

Journal Articles

A randomized study of conventional chemotherapy +/- uproleselan in older adults with Acute Myeloid Leukemia eceiving intensive induction chemotherapy (Alliance A041701)

Blood (2025) 146 (Supplement 1): 3415.

https://doi.org/10.1182/blood-2025-3415

Published: 2025

Journal Articles

Normal B Cells in MBL follow divergent maturation pathways that correlate with the IGHV mutation status of the pre-leukemic clone

Gonzalo Blanco, Xiao Yan, Anita Kar Yun Ng, Andrew Shih, Jacqueline Aldridge, Anna Puiggros, Lindybeth Sarmiento, Jonathan Kolitz, Steven Allen, Kanti Rai, Douglas Stewart, Blanca Espinet, Gerald Marti, Neil Caporaso, Marcelo Navarrete, Nicholas Chiorazzi

Blood (2025) 146 (Supplement 1): 3910.

https://doi.org/10.1182/blood-2025-3910

Published: 2025

Journal Articles

TP53-mutated AML and treatment outcomes in the era of hypomethylating agent/venetoclax therapy

David Mueller, Sharon Santhosh, Adit Singhal, David W. Chitty, Douglas Gladstone, Bradley Goldberg, Erin Jou, Jonathan Kolitz, Stephanie Boisclair

Blood (2025) 146 (Supplement 1): 1705.

https://doi.org/10.1182/blood-2025-1705

Published: 2025

Journal Articles

Tri-partied analyses define clinical outcomes and molecular features of patients (pts) with acute promyelocytic leukemia (APL)

Blood (2025) 146 (Supplement 1): 8183.

https://doi.org/10.1182/blood-2025-8183

Published: 2025

Journal Articles

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

Shih-Shih Chen, Ph.D., Matthew Kaufman, M.D., Angelica Caramanica, Rajendra N Damle, Ph.D., Peter Garofalo, Patricia Ly, Dale Janson, Steven L. Allen, M.D., Jonathan Kolitz, M.D., Linda Quill, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2010) 116 (21): 1392.

https://doi.org/10.1182/blood.V116.21.1392.1392

Published: 2010

Journal Articles

Activation of Nucleic Acid-Sensing Toll-Like Receptors Induces Proliferation, Cytokine Production, Immunogenic Phenotype, and Plasma Cell Differentiation of CLL Cells and Immunoglobulin Production.

Santanu Paul, PhD, Charles C. Chu, PhD, Brian A. McCarthy, PhD, Erin Boyle, BS, Bettie M. Steinberg, PhD, Matthew Kaufman, MD, Jonathan Kolitz, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2007) 110 (11): 1137.

https://doi.org/10.1182/blood.V110.11.1137.1137

Published: 2007

Journal Articles

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Mikkael A. Sekeres, Bercedis Peterson, Richard K. Dodge, Robert J. Mayer, Joseph O. Moore, Edward J. Lee, Jonathan Kolitz, Maria R. Baer, Charles A. Schiffer, Andrew J. Carroll, James W. Vardiman, Frederick R. Davey, Clara D. Bloomfield, Richard A. Larson, Richard M. Stone, for the Cancer and Leukemia Group B (CALGB)

Blood (2004) 103 (11): 4036–4042.

https://doi.org/10.1182/blood-2003-09-3118

Published: 2004

Journal Articles

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations

Rajendra N. Damle, Franak M. Batliwalla, Fabio Ghiotto, Angelo Valetto, Emilia Albesiano, Cristina Sison, Steven L. Allen, Jonathan Kolitz, Vincent P. Vinciguerra, Prasad Kudalkar, Tarun Wasil, Kanti R. Rai, Manlio Ferrarini, Peter K. Gregersen, Nicholas Chiorazzi

Blood (2004) 103 (2): 375–382.

https://doi.org/10.1182/blood-2003-04-1345

Published: 2004

Journal Articles

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes: Presented in part at the 42nd Annual Meeting of the American Society of Hematology, December 1-5, 2000, San Francisco, CA.

Rajendra N. Damle, Fabio Ghiotto, Angelo Valetto, Emilia Albesiano, Franco Fais, Xiao-Jie Yan, Cristina P. Sison, Steven L. Allen, Jonathan Kolitz, Philip Schulman, Vincent P. Vinciguerra, Petra Budde, Jurgen Frey, Kanti R. Rai, Manlio Ferrarini, Nicholas Chiorazzi

Blood (2002) 99 (11): 4087–4093.

https://doi.org/10.1182/blood.V99.11.4087

Published: 2002

Journal Articles

Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia: Presented in part at the 40 th Annual Meeting of The American Society of Hematology, held in Miami Beach, FL, December 4-8, 1998.

Rajendra N. Damle, Tarun Wasil, Franco Fais, Fabio Ghiotto, Angelo Valetto, Steven L. Allen, Aby Buchbinder, Daniel Budman, Klaus Dittmar, Jonathan Kolitz, Stuart M. Lichtman, Philip Schulman, Vincent P. Vinciguerra, Kanti R. Rai, Manlio Ferrarini, Nicholas Chiorazzi

Blood (1999) 94 (6): 1840–1847.

https://doi.org/10.1182/blood.V94.6.1840

Published: 1999

Journal Articles

Correlation Between Mutation in P53, p53 Expression, Cytogenetics, Histologic Type, and Survival in Patients With B-Cell Non-Hodgkin's Lymphoma

Prasad R.K. Koduru, Karthik Raju, Veena Vadmal, Geetha Menezes, Shefali Shah, Myron Susin, Jonathan Kolitz, John D. Broome

Blood (1997) 90 (10): 4078–4091.

https://doi.org/10.1182/blood.V90.10.4078

Published: 1997

Journal Articles

Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquinone and Mitoxantrone: Cancer and Leukemia Group B Study 9022

Joseph O. Moore, Richard K. Dodge, Philip C. Amrein, Jonathan Kolitz, Edward J. Lee, Bayard Powell, Scott Godfrey, Francisco Robert, Charles A. Schiffer

Blood (1997) 89 (3): 780–788.

https://doi.org/10.1182/blood.V89.3.780

Published: 1997

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Real-world experience with front-line metronomic low-dose weekly decitabine and venetoclax in elderly and/or frail patients with MDS or AML

17p cytogenetic changes in TP53-mutated AML

Foreign antigen delivered to CLL B cells via membrane IgD leads to a distinct antigen processing pathway that allows antigen-specific T cell activation that is superior to membrane IgM delivery

Predictors of 90-day mortality in elderly and unfit AML patients treated with single-agent hypomethylating agents or in combination with venetoclax

A randomized study of conventional chemotherapy +/- uproleselan in older adults with Acute Myeloid Leukemia eceiving intensive induction chemotherapy (Alliance A041701)

Normal B Cells in MBL follow divergent maturation pathways that correlate with the IGHV mutation status of the pre-leukemic clone

TP53-mutated AML and treatment outcomes in the era of hypomethylating agent/venetoclax therapy

Tri-partied analyses define clinical outcomes and molecular features of patients (pts) with acute promyelocytic leukemia (APL)

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

Activation of Nucleic Acid-Sensing Toll-Like Receptors Induces Proliferation, Cytokine Production, Immunogenic Phenotype, and Plasma Cell Differentiation of CLL Cells and Immunoglobulin Production.

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes: Presented in part at the 42nd Annual Meeting of the American Society of Hematology, December 1-5, 2000, San Francisco, CA.

Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia: Presented in part at the 40 th Annual Meeting of The American Society of Hematology, held in Miami Beach, FL, December 4-8, 1998.

Correlation Between Mutation in P53, p53 Expression, Cytogenetics, Histologic Type, and Survival in Patients With B-Cell Non-Hodgkin's Lymphoma

Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquinone and Mitoxantrone: Cancer and Leukemia Group B Study 9022

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only